Chengdu Shengnuo Biopharm Co., Ltd. is a specialized, sophisticated, and innovative enterprise and a national high-tech enterprise specializing in the peptide field,
which went public in 2021. We integrate R&D, production, and sales, with business covering peptide active pharmaceutical ingredients (APIs), cosmetic bioactive peptides, CDMO services, and peptide formulations.
As a leading company in China's peptide API sector, we focus on the development, production, and technical services of peptide drugs, possessing full industrial chain capabilities from drug discovery to commercial manufacturing.